Obesity and respiratory infections: Does excess adiposity weigh down host defense?

Pulmonary Pharmacology and Therapeutics

Volumn 26, Issue 4, 2013, Pages 412-419

  Mancuso, Peter ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Bacteria; Human; Infection; Influenza; Mice; Obesity; Pneumonia

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; FATTY ACID; INTERLEUKIN 1; INTERLEUKIN 18; INTERLEUKIN 6; LEPTIN; LEPTIN RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; RESISTIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

2009 H1N1 INFLUENZA; ADAPTIVE IMMUNITY; ADIPOSE TISSUE; ARTICLE; CARDIOVASCULAR DISEASE; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; FATTY ACID BLOOD LEVEL; GASTROESOPHAGEAL REFLUX; HOSPITAL INFECTION; HOST RESISTANCE; HUMAN; HYPERGLYCEMIA; INFLUENZA VACCINATION; INNATE IMMUNITY; LEPTIN DEFICIENCY; METABOLIC DISORDER; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RISK FACTOR; SIGNAL TRANSDUCTION; STREPTOCOCCUS PNEUMONIA; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOSITY; ANIMALS; BACTERIAL INFECTIONS; DISEASE MODELS, ANIMAL; HUMANS; INFLUENZA, HUMAN; LEPTIN; MICE; OBESITY; PNEUMONIA; RECEPTORS, LEPTIN; RESPIRATORY TRACT INFECTIONS; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 84880510658     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2012.04.006     Document Type: Article

References (101)

1. Flegal K.M., Carroll M.D., Ogden C.L., Curtin L.R. Prevalence and trends in obesity among US adults, 1999-2008. JAMA Jan 20 2010, 303(3):235-241.
2. Doyle S.L., Lysaght J., Reynolds J.V. Obesity and post-operative complications in patients undergoing non-bariatric surgery. Obes Rev Dec 2010, 11(12):875-886.
3. Finucane M.M., Stevens G.A., Cowan M.J., Danaei G., Lin J.K., Paciorek C.J., et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet Feb 12 2011, 377(9765):557-567.
4. Bochicchio G.V., Joshi M., Bochicchio K., Nehman S., Tracy J.K., Scalea T.M. Impact of obesity in the critically ill trauma patient: a prospective study. JAm Coll Surg Oct 2006, 203(4):533-538.
5. Intensive-care patients with severe novel influenza A (H1N1) virus infection - Michigan, June 2009. MMWR Morb Mortal Wkly Rep Jul 17 2009, 58(27):749-752.
6. Newell M.A., Bard M.R., Goettler C.E., Toschlog E.A., Schenarts P.J., Sagraves S.G., et al. Body mass index and outcomes in critically injured blunt trauma patients: weighing the impact. JAm Coll Surg May 2007, 204(5):1056-1061. [discussion 1062-4].
7. Yaegashi M., Jean R., Zuriqat M., Noack S., Homel P. Outcome of morbid obesity in the intensive care unit. JIntensive Care Med May-Jun 2005, 20(3):147-154.
8. Fuhrman C., Bonmarin I., Bitar D., Cardoso T., Duport N., Herida N., et al. Adult intensive-care patients with 2009 pandemic influenza A(H1N1) infection. Epidemiol Infect Oct 26 2010, 1-8.
9. Ahima R.S. Digging deeper into obesity. JClin Invest 2011, 121(6):2076-2079.
10. Koenig S.M. Pulmonary complications of obesity. Am J Med Sci Apr 2001, 321(4):249-279.
11. Valdez R., Narayan K.M., Geiss L.S., Engelgau M.M. Impact of diabetes mellitus on mortality associated with pneumonia and influenza among non-Hispanic black and white US adults. Am J Public Health November 1, 1999, 89(11):1715-1721.
12. Lagergren J. Influence of obesity on the risk of esophageal disorders. Nat Rev Gastroenterol Hepatol 2011, 8(6):340-347.
13. Marik P., Varon J. The obese patient in the ICU. Chest 1998, 113:492-498.
14. Falagas M.E., Kompoti M. Obesity and infection. Lancet Infect Dis Jul 2006, 6(7):438-446.
15. Carter P.R. Association between gastroesophageal reflux disease and laparoscopic sleeve gastrectomy. Surg Obes Relat Dis 2011, 7(5):569-572.
16. Tutuian R. Obesity and GERD: pathophysiology and effect of bariatric surgery. Curr Gastroenterol Rep 2011, 13(3):205-212.
17. Shah B.R., Hux J.E. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care February 1, 2003, 26(2):510-513.
18. O'Brien K.B., Vogel P., Duan S., Govorkova E.A., Webby R.J., McCullers J.A., et al. Impaired wound healing predisposes obese mice to severe influenza virus infection. JInfect Dis January 15, 2012, 205(2):252-261.
19. Yende S., van der Poll T., Lee M., Huang D.T., Newman A.B., Kong L., et al. The influence of pre-existing diabetes mellitus on the host immune response and outcome of pneumonia: analysis of two multicentre cohort studies. Thorax October 1, 2010, 65(10):870-877.
20. Goossens G.H. The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance. Physiol Behav May 23 2008, 94(2):206-218.
21. Karlsson E.A., Sheridan P.A., Beck M.A. Diet-induced obesity in mice reduces the maintenance of influenza-specific CD8+ memory T cells. JNutr Sep 2010, 140(9):1691-1697.
22. Donath M.Y., Shoelson S.E. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol Feb 2011, 11(2):98-107.
23. Vaillant L., La Ruche G., Tarantola A., Barboza P. Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Euro Surveill 2009, 14(33).
24. La Ruche G., Tarantola A., Barboza P., Vaillant L., Gueguen J., Gastellu-Etchegorry M. The 2009 pandemic H1N1 influenza and indigenous populations of the Americas and the Pacific. Euro Surveill 2009, 14(42).
25. Gill J.R., Sheng Z.M., Ely S.F., Guinee D.G., Beasley M.B., Suh J., et al. Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections. Arch Pathol Lab Med Feb 2010, 134(2):235-243.
26. Jain S., Kamimoto L., Bramley A.M., Schmitz A.M., Benoit S.R., Louie J., et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. New Engl J Med 2009, 361(20):1935-1944.
27. Fezeu L., Julia C., Henegar A., Bitu J., Hu F.B., Grobbee D.E., et al. Obesity is associated with higher risk of intensive care unit admission and death in influenza A (H1N1) patients: a systematic review and meta-analysis. Obes Rev Apr 4 2011.
28. Dominguez-Cherit G., Lapinsky S.E., Macias A.E., Pinto R., Espinosa-Perez L., de la Torre A., et al. Critically Ill patients with 2009 influenza A(H1N1) in Mexico. JAMA Nov 4 2009, 302(17):1880-1887.
29. Jhung M.A., Swerdlow D., Olsen S.J., Jernigan D., Biggerstaff M., Kamimoto L., et al. Epidemiology of 2009 pandemic influenza A (H1N1) in the United States. Clin Infect Dis January 1, 2011, 52(suppl 1):S13-S26.
30. Fuhrman C., Bonmarin I., Paty A.C., Duport N., Chiron E., Lucas E., et al. Severe hospitalised 2009 pandemic influenza A(H1N1) cases in France, 1 July-15 November 2009. Euro Surveill Jan 14 2010, 15(2).
31. Sigurdsson G.H., Moller A.D., Kristinsson B., Gudlaugsson O., Karason S., Sigurdsson S.E., et al. Intensive care patients with influenza A (H1N1) infection in Iceland 2009. Laeknabladid Feb 2010, 96(2):83-90.
32. Mayoral Cortes J.M., Ruiz Fernandez J., Pachon Diaz J., Navarro Mari J.M., Puell Gomez L., Perez Morilla E., et al. Infection by the pandemic virus (H1N1) 2009 in Andalusia. Rev Esp Salud Publica Sep-Oct 2010, 84(5):517-528.
33. Dee S., Jayathissa S. Clinical and epidemiological characteristics of the hospitalised patients due to pandemic H1N1 2009 viral infection: experience at Hutt Hospital, New Zealand. NZ Med J Apr 9 2010, 123(1312):45-53.
34. Gauzere B.A., Bussienne F., Bouchet B., Jabot J., Roussiaux A., Drouet D., et al. Severe cases of A(H1N1)v2009 infection in Reunion island in 2009 and 2010. Bull Soc Pathol Exot May 2011, 104(2):97-104.
35. Cardenosa N., Rodes A., Follia N., Plasencia E., Lafuente S., Arias C., et al. Epidemiological analysis of severe hospitalized 2009 pandemic influenza A (H1N1) cases in Catalonia, Spain. Hum Vaccin Jan 1 2011, 7:226-229.
36. Sheridan P.A., Paich H.A., Handy J., Beck M.A. Obesity is associated with impaired immune response to influenza vaccination in humans. Int J Obes (Lond) Oct 25 2011.
37. Buettner R., Scholmerich J., Bollheimer L.C. High-fat diets: modeling the metabolic disorders of human obesity in Rodents[ast]. Obesity 2007, 15(4):798-808.
38. Smith A.G., Sheridan P.A., Harp J.B., Beck M.A. Diet-induced obese mice have increased mortality and altered immune responses when infected with influenza virus. JNutr May 2007, 137(5):1236-1243.
39. Smith A.G., Sheridan P.A., Tseng R.J., Sheridan J.F., Beck M.A. Selective impairment in dendritic cell function and altered antigen-specific CD8+ T-cell responses in diet-induced obese mice infected with influenza virus. Immunology Feb 2009, 126(2):268-279.
40. Easterbrook J.D., Dunfee R.L., Schwartzman L.M., Jagger B.W., Sandouk A., Kash J.C., et al. Obese mice have increased morbidity and mortality compared to non-obese mice during infection with the 2009 pandemic H1N1 influenza virus. Influenza Other Respi Viruses 2011.
41. Karlsson E.A., Sheridan P.A., Beck M.A. Diet-induced obesity impairs the T cell memory response to influenza virus infection. JImmunol Mar 15 2010, 184(6):3127-3133.
42. Corrales-Medina V.F., Valayam J., Serpa J.A., Rueda A.M., Musher D.M. The obesity paradox in community-acquired bacterial pneumonia. Int J Infect Dis Jan 2011, 15(1):e54-e57.
43. LaCroix A.Z., Lipson S., Miles T.P., White L. Prospective study of pneumonia hospitalizations and mortality of U.S. older people: the role of chronic conditions, health behaviors, and nutritional status. Public Health Rep Jul-Aug 1989, 104(4):350-360.
44. Inoue Y., Koizumi A., Wada Y., Iso H., Watanabe Y., Date C., et al. Risk and protective factors related to mortality from pneumonia among middleaged and elderly community residents: the JACC study. JEpidemiol Nov 2007, 17(6):194-202.
45. Baik I., Curhan G.C., Rimm E.B., Bendich A., Willett W.C., Fawzi W.W. Aprospective study of age and lifestyle factors in relation to community-acquired pneumonia in US men and women. Arch Intern Med Nov 13 2000, 160(20):3082-3088.
46. Jedrychowski W., Maugeri U., Flak E., Mroz E., Bianchi I. Predisposition to acute respiratory infections among overweight preadolescent children: an epidemiologic study in Poland. Public Health May 1998, 112(3):189-195.
47. Choban P.S., Heckler R., Burge J.C., Flancbaum L. Increased incidence of nosocomial infections in obese surgical patients. Am Surg Nov 1995, 61(11):1001-1005.
48. Dossett L.A., Dageforde L.A., Swenson B.R., Metzger R., Bonatti H., Sawyer R.G., et al. Obesity and site-specific nosocomial infection risk in the intensive care unit. Surg Infect (Larchmt) Apr 2009, 10(2):137-142.
49. Canturk Z., Canturk N.Z., Cetinarslan B., Utkan N.Z., Tarkun I. Nosocomial infections and obesity in surgical patients. Obes Res Jun 2003, 11(6):769-775.
50. Serrano P.E., Khuder S.A., Fath J.J. Obesity as a risk factor for nosocomial infections in trauma patients. JAm Coll Surg 2010, 211(1):61-67.
51. Brandt M., Harder K., Walluscheck K.P., Schottler J., Rahimi A., Moller F., et al. Severe obesity does not adversely affect perioprative mortality and morbidity in coronary artery bypass surgery. Eur J Cardiothorac Surg 2001, 19(5):662-666.
52. Moulton M.J., Creswell L.L., Mackey M.E., Cox J.L., Rosenbloom M. Obesity is not a risk factor for significant adverse outcomes after cardiac surgery. Circulation Nov 1 1996, 94(9 Suppl):II87-II92.
53. Dossett L.A., Heffernan D., Lightfoot M., Collier B., Diaz J.J., Sawyer R.G., et al. Obesity and pulmonary complications in critically injured adults. Chest Nov 2008, 134(5):974-980.
54. Mancuso P., Gottschalk A., Phare S.M., Peters-Golden M., Lukacs N.W., Huffnagle G.B. Leptin-deficient mice exhibit impaired host defense in gram-negative pneumonia. JImmunol April 15, 2002, 168(8):4018-4024.
55. Hsu A., Aronoff D.M., Phipps J., Goel D., Mancuso P. Leptin improves pulmonary bacterial clearance and survival in ob/ob mice during pneumococcal pneumonia. Clin Exp Immunol Nov 2007, 150(2):332-339.
56. Ordway D., Henao-Tamayo M., Smith E., Shanley C., Harton M., Troudt J., et al. Animal model of Mycobacterium abscessus lung infection. JLeukoc Biol Jun 2008, 83(6):1502-1511.
57. Wieland C.W., Florquin S., Chan E.D., Leemans J.C., Weijer S., Verbon A., et al. Pulmonary Mycobacterium tuberculosis infection in leptin-deficient ob/ob mice. Int Immunol November 1, 2005, 17(11):1399-1408.
58. Webb S.R., Loria R.M., Madge G.E., Kibrick S. Susceptibility of mice to group B coxsackie virus is influenced by the diabetic gene. JExp Med May 1 1976, 143(5):1239-1248.
59. Fernandez-Riejos P., Najib S., Santos-Alvarez J., Martin-Romero C., Perez-Perez A., Gonzalez-Yanes C., et al. Role of leptin in the activation of immune cells. Mediators Inflamm 2010, 568343.
60. Lord G.M., Matarese G., Howard J.K., Baker R.J., Bloom S.R., Lechler R.I. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998, 394:897-901.
61. Loffreda S., Yang S., Lin H., Karp C., Brengman M., Wang D., et al. Leptin regulates proinflammatory immune responses. FASEB J 1998, 12:57-65.
62. 2γ) protein expression. Am J Physiol Lung Cell Mol Physiol 2004, 287:L497-L502.
63. Bruno A., Conus S., Schmid I., Simon H.-U. Apoptotic pathways are inhibited by leptin receptor activation in neutrophils. JImmunol June 15, 2005, 174(12):8090-8096.
64. Wieland C.W., Stegenga M.E., Florquin S., Fantuzzi G., van der Poll T. Leptin and host defense against gram-positive and gram-negative pneumonia in mice. Shock 2006, 25(April):414-419.
65. Mattioli B., Straface E., Quaranta M.G., Giordani L., Viora M. Leptin promotes differentiation and survival of human dendritic cells and licenses them for Th1 priming. JImmunol June 1, 2005, 174(11):6820-6828.
66. Santos-Alvarez J., Goberna R., Sanchez-Margalet V. Human leptin stimulates proliferation and activation of human circulating monocytes. Cell Immunol 1999, 194:6-11.
67. Moore S.I., Huffnagle G.B., Chen G.H., White E.S., Mancuso P. Leptin modulates neutrophil phagocytosis of Klebsiella pneumoniae. Infect Immun Jul 2003, 71(7):4182-4185.
68. Caldefie-Chezet F., Poulin A., Tridon A., Sion B., Vasson M.P. Leptin: a potential regulator of polymorphonuclear neutrophil bactericidal action?. JLeukoc Biol Mar 2001, 69(3):414-418.
69. De Minicis S., Seki E., Oesterreicher C., Schnabl B., Schwabe R.F., Brenner D.A. Reduced nicotinamide adenine dinucleotide phosphate oxidase mediates fibrotic and inflammatory effects of leptin on hepatic stellate cells. Hepatology Dec 2008, 48(6):2016-2026.
70. Mancuso P., Huffnagle G.B., Olszewski M.A., Phipps J., Peters-Golden M. Leptin corrects host defense defects following acute starvation in murine pneumococcal pneumonia. Am J Respir Crit Care Med 2006, 173(Jan 15):212-218.
71. Bailie M.B., Standiford T.J., Laichalk L.L., Coffey M.J., Strieter R.M., Peters-Golden M. Leukotriene-deficient mice manifest enhanced lethality from Klebsiella pneumonia in association with decreased alveolar macrophage phagocytic and bactericidal activities. JImmunol 1996, 157:5221-5224.
72. 4 enhances pulmonary host defense against pneumococcal pneumonia. Infect Immun 2010, 78:2261-2271.
73. Maya-Monteiro C.M., Almeida P.E., D'Avila H., Martins A.S., Rezende A.P., Castro-Faria-Neto H., et al. Leptin induces macrophage lipid body formation by a phosphatidylinositol 3-kinase- and mammalian target of rapamycin-dependent mechanism. JBiol Chem Jan 25 2008, 283(4):2203-2210.
74. Mancuso P., Peters-Golden M., Goel D., Goldberg J., Brock T.G., Greenwald-Yarnell M., et al. Disruption of leptin receptor-STAT3 signaling enhances leukotriene production and pulmonary host defense against pneumococcal pneumonia. JImmunol 2011, 186:1081-1090.
75. Tschop J., Nogueiras R., Haas-Lockie S., Kasten K.R., Castaneda T.R., Huber N., et al. CNS leptin action modulates immune response and survival in sepsis. JNeurosci Apr 28 2010, 30(17):6036-6047.
76. Ikejima S., Sasaki S., Sashinami H., Iso H., Watanabe Y., Date C., et al. Impairment of host resistance to Listeria monocytogenes infection in liver of db/db and ob/ob mice. Diabetes January 1, 2005, 54(1):182-189.
77. Park S., Rich J., Hanses F., Lee J.C. Defects in innate immunity predispose C57BL/6J-Leprdb/Leprdb mice to infection by Staphylococcus aureus. Infect Immun Mar 2009, 77(3):1008-1014.
78. Wehrens A., Aebischer T., Meyer T.F., Walduck A.K. Leptin receptor signaling is required for vaccine-induced protection against Helicobacter pylori. Helicobacter Apr 2008, 13(2):94-102.
79. D'Andrea B.J., Wilson G.L., Craighead J.E. Effect of genetic obesity in mice on the induction of diabetes by encephalomyocarditis virus. Diabetes May 1981, 30(5):451-454.
80. Guo X., Roberts M.R., Becker S.M., Podd B., Zhang Y., Chua S.C., et al. Leptin signaling in intestinal epithelium mediates resistance to enteric infection by Entamoeba histolytica. Mucosal Immunol May 2011, 4(3):294-303.
81. Ozata M., Ozdemir I.C., Licinio J. Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. JClin Endocrinol Metab Oct 1999, 84(10):3686-3695.
82. Friedman J.M., Halaas J.L. Leptin and the regulation of body weight in mammals. Nature Oct 22 1998, 395(6704):763-770.
83. Reed A.S., Unger E.K., Olofsson L.E., Piper M.L., Myers M.G., Xu A.W. Functional role of suppressor of cytokine signaling 3 upregulation in hypothalamic leptin resistance and long-term energy homeostasis. Diabetes Apr 2010, 59(4):894-906.
84. Nave H., Mueller G., Siegmund B., Jacobs R., Stroh T., Schueler U., et al. Resistance of Janus kinase-2 dependent leptin signaling in natural killer (NK) cells: a novel mechanism of NK cell dysfunction in diet-induced obesity. Endocrinology Jul 2008, 149(7):3370-3378.
85. Papathanassoglou E., El-Haschimi K., Li X.C., Matarese G., Strom T., Mantzoros C. Leptin receptor expression and signaling in lymphocytes: kinetics during lymphocyte activation, role in lymphocyte survival, and response to high fat diet in mice. JImmunol Jun 15 2006, 176(12):7745-7752.
86. Tsiotra P.C., Pappa V., Raptis S.A., Tsigos C. Expression of the long and short leptin receptor isoforms in peripheral blood mononuclear cells: implications for leptin's actions. Metabolism 2000, 49(12):1537-1541.
87. Farooqi I.S., Bullmore E., Keogh J., Gillard J., O'Rahilly S., Fletcher P.C. Leptin regulates striatal regions and human eating behavior. Science Sep 7 2007, 317(5843):1355.
88. Duggal P., Guo X., Haque R., Peterson K.M., Ricklefs S., Mondal D., et al. Amutation in the leptin receptor is associated with Entamoeba histolytica infection in children. JClin Invest 2011, 121(3):1191-1198.
89. Summer R., Little F.F., Ouchi N., Takemura Y., Aprahamian T., Dwyer D., et al. Alveolar macrophage activation and an emphysema-like phenotype in adiponectin-deficient mice. Am J Physiol Lung Cell Mol Physiol Jun 2008, 294(6):L1035-L1042.
90. Shore S.A., Terry R.D., Flynt L., Xu A., Hug C. Adiponectin attenuates allergen-induced airway inflammation and hyperresponsiveness in mice. JAllergy Clin Immunol Aug 2006, 118(2):389-395.
91. Medoff B.D., Okamoto Y., Leyton P., Weng M., Sandall B.P., Raher M.J., et al. Adiponectin-deficiency increases allergic airway inflammation and pulmonary vascular remodeling. Am J Respir Cell Mol Biol Jan 23 2009.
92. Ouchi N., Parker J.L., Lugus J.J., Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol Feb 2011, 11(2):85-97.
93. Tasaka S., Hasegawa N., Nishimura T., Yamasawa W., Kamata H., Shinoda H., et al. Elevated serum adiponectin level in patients with Mycobacterium avium-intracellulare complex pulmonary disease. Respiration 2010, 79(5):383-387.
94. Clinthorne J.F., Adams D.J., Fenton J.I., Ritz B.W., Gardner E.M. Short-term re-feeding of previously energy-restricted C57BL/6 male mice restores body weight and body fat and attenuates the decline in natural killer cell function after primary influenza infection. JNutr Aug 2010, 140(8):1495-1501.
95. Uji Y., Yamamoto H., Tsuchihashi H., Maeda K., Funahashi T., Shimomura I., et al. Adiponectin deficiency is associated with severe polymicrobial sepsis, high inflammatory cytokine levels, and high mortality. Surgery May 2009, 145(5):550-557.
96. Takemura Y., Ouchi N., Shibata R., Aprahamian T., Kirber M.T., Summer R.S., et al. Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies. JClin Invest Feb 2007, 117(2):375-386.
97. Saijo S., Nagata K., Nakano Y., Tobe T., Kobayashi Y. Inhibition by adiponectin of IL-8 production by human macrophages upon coculturing with late apoptotic cells. Biochem Biophys Res Commun Sep 9 2005, 334(4):1180-1183.
98. Nakanishi S., Yamane K., Kamei N., Nojima H., Okubo M., Kohno N. Aprotective effect of adiponectin against oxidative stress in Japanese Americans: the association between adiponectin or leptin and urinary isoprostane. Metabolism Feb 2005, 54(2):194-199.
99. Sowers M.R., Wildman R.P., Mancuso P., Eyvazzadeh A.D., Karvonen-Gutierrez C.A., Rillamas-Sun E., et al. Change in adipocytokines and ghrelin with menopause. Maturitas Feb 20 2008, 59(2):149-157.
100. Wu H., Santoni-Rugiu E., Ralfkiaer E., Porse B., Moser C., Hoiby N., et al. Lipocalin 2 is protective against E. coli pneumonia. Respir Res 2010, 11(1):96.
101. Chan Y.R., Liu J.S., Pociask D.A., Zheng M., Mietzner T.A., Berger T., et al. Lipocalin 2 is required for pulmonary host defense against Klebsiella infection. JImmunol Apr 15 2009, 182(8):4947-4956.